Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
Open-market buys, last 90 days
$99,331
in 1 filing
Open-market sales, last 90 days
$297,289
in 4 filings, $297K under 10b5-1 plans

Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-21 Cochran John Director Other acquisition +62,229 161,715
2026-06-10 Cochran John Director Grant or award · Stock Option (Right to Purchase) +50,500 50,500
2025-06-11 Cochran John Director Grant or award · Stock Option (Right to Purchase) +42,000 $3.41 $143K 42,000
2024-06-20 Cochran John Director Grant or award · Stock Option (Right to Purchase) +38,000 38,000
2023-06-21 Cochran John Director Grant or award · Stock Option (Right to Purchase) +25,000 25,000
2022-06-22 Cochran John Director Grant or award · Stock Option (Right to Purchase) +25,000 25,000
2021-06-15 Cochran John Director Grant or award · Stock Option (Right to Purchase) +20,000 20,000
2021-05-10 Cochran John Director Gift −37,500 99,486
2021-03-12 Cochran John Director Other acquisition +23,038 98,123
2021-03-12 Cochran John Director Other acquisition +8,228 106,351
2021-03-12 Cochran John Director Other acquisition +11,544 117,895
2021-03-12 Cochran John Director Other acquisition +19,091 136,986
2020-06-16 Cochran John Director Grant or award · Stock Option (Right to Purchase) +14,000 14,000
2019-06-13 Cochran John Director Grant or award · Stock Option (Right to Purchase) +13,350 13,350
2018-07-24 Cochran John Director Grant or award · Stock Option (Right to Purchase) +26,700 26,700

Page 1 of 1 · 15 trades